Effect of fluirbiprofen and lidocaine on sore throat due to the upper gastrointestinal system endoscopy

Phase 4

Recruiting

• Conditions: Surgery; Ear, Nose and Throat; Anaesthesia

• Registration Number: PACTR201901699494129
• Lead Sponsor: Mogadishu Somali Turkey Recep Tayyip Erdogan Training and Research Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. 18-60 years of age elective endoscopy to be applied
2. American society of Anesthesia I-II
3. Mallampati I-II
4. Patients who have not undergone surgery
5. Patients have not received radiotherapy

Exclusion Criteria

1. Patients who do not agree to participate in the study
2. Upper airway anomaly or infection
3. Smokers with sore throat
4. Endoscopes failed on first entry
5. Pregnant, those with drug allergy
6. Cases of emergency surgery,
7. Patients who have previously used Flurbiprofen
8. Patients without co-operation
9. Nazogastric catheter insertion

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Find the incidence of sore throat due to the application of upper gastrointestinal system endoscopy and compare the effectiveness of lidocaine and flurbiprofen with the saline group

Secondary Outcome Measures

Name	Time	Method
To evaluate possible side effects of lidocaine, flurbiprofen used in the treatment of sore throat due to upper gastrointestinal endoscopy